Sign in

CIK 0001798749

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
  1. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  2. 8-K Event Executive or director change
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
  6. 8-K Event Acquisition or sale completed · Results of operations · Regulation FD disclosure
  7. 8-K Event Material agreement · Acquisition or sale completed · Results of operations · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure
  8. 8-K Event Regulation FD disclosure
  9. 10-Q Report Quarterly Report
  10. 8-K Event Other events
  11. 8-K Event Shareholder vote results · Regulation FD disclosure · Other events
  12. 8-K Event Regulation FD disclosure · Other events
  13. 8-K Event Other events
  14. 8-K Event Regulation FD disclosure · Other events
  15. 10-K Report Annual Report
  16. 10-Q Report Quarterly Report
  17. 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
  18. 8-K Event Delisting notice
  19. 8-K Event Executive or director change
  20. 10-Q Report Quarterly Report

Page 2 of 5 · 83 filings